FDA Inspection 1291928 — Lumara Bio USA Inc
The FDA completed an inspection of Lumara Bio USA Inc on Nov 6, 2025 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 6, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Princeton, NJ (United States)
Additional details
Sponsor, Contract Research Organization